17543143

Source:http://linkedlifedata.com/resource/pubmed/id/17543143

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0034606, umls-concept:C0087111, umls-concept:C0145942, umls-concept:C0181734, umls-concept:C0246719, umls-concept:C0262950, umls-concept:C0441655, umls-concept:C1280500, umls-concept:C1368019, umls-concept:C1516048, umls-concept:C2348205
pubmed:issue	2
pubmed:dateCreated	2007-6-4
pubmed:abstractText	To compare the effects of tiludronate and risedronate on Paget's disease activity assessed by biochemical markers of bone turnover and quantitative bone scintigraphy.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/8308521
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Alkaline Phosphatase, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/Bone Density Conservation Agents, http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I, http://linkedlifedata.com/resource/pubmed/chemical/Creatinine, http://linkedlifedata.com/resource/pubmed/chemical/Diphosphonates, http://linkedlifedata.com/resource/pubmed/chemical/Etidronic Acid, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments, http://linkedlifedata.com/resource/pubmed/chemical/Peptides, http://linkedlifedata.com/resource/pubmed/chemical/Procollagen, http://linkedlifedata.com/resource/pubmed/chemical/collagen type I trimeric..., http://linkedlifedata.com/resource/pubmed/chemical/procollagen Type I N-terminal..., http://linkedlifedata.com/resource/pubmed/chemical/risedronic acid, http://linkedlifedata.com/resource/pubmed/chemical/tiludronic acid
pubmed:status	MEDLINE
pubmed:issn	0392-856X
pubmed:author	pubmed-author:AlvarezLL, pubmed-author:GuañabensNN, pubmed-author:MartínezM AMA, pubmed-author:MonegalAA, pubmed-author:PerisPP, pubmed-author:VidalSS
pubmed:issnType	Print
pubmed:volume	25
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	206-10
pubmed:meshHeading	pubmed-meshheading:17543143-Adult, pubmed-meshheading:17543143-Aged, pubmed-meshheading:17543143-Aged, 80 and over, pubmed-meshheading:17543143-Alkaline Phosphatase, pubmed-meshheading:17543143-Biological Markers, pubmed-meshheading:17543143-Bone Density Conservation Agents, pubmed-meshheading:17543143-Collagen Type I, pubmed-meshheading:17543143-Creatinine, pubmed-meshheading:17543143-Diphosphonates, pubmed-meshheading:17543143-Etidronic Acid, pubmed-meshheading:17543143-Female, pubmed-meshheading:17543143-Humans, pubmed-meshheading:17543143-Male, pubmed-meshheading:17543143-Middle Aged, pubmed-meshheading:17543143-Osteitis Deformans, pubmed-meshheading:17543143-Peptide Fragments, pubmed-meshheading:17543143-Peptides, pubmed-meshheading:17543143-Procollagen, pubmed-meshheading:17543143-Radionuclide Imaging
pubmed:articleTitle	Treatment with tiludronate has a similar effect to risedronate on Paget's disease activity assessed by bone markers and bone scintigraphy.
pubmed:affiliation	Services of Rheumatology, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. 22848ppb@comb.es
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Research Support, Non-U.S. Gov't